ARD Podcast
Health & Wellness Podcasts
Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer-reviewed proceedings of international meetings are featured. ARD is the official journal of EULAR.
Location:
United Kingdom
Genres:
Health & Wellness Podcasts
Description:
Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer-reviewed proceedings of international meetings are featured. ARD is the official journal of EULAR.
Twitter:
@ARD_BMJ
Language:
English
Email:
botoole@bmj.com
Managing Systemic Lupus Erythematosus: the latest EULAR recommendations
Duration:00:21:25
A non-pharma approach in systemic lupus erythematosus and systemic sclerosis
Duration:00:18:55
Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin
Duration:00:21:36
Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases
Duration:00:20:37
The EULAR COVID-19 database and its insights into risk factors
Duration:00:25:42
Predictors of disease worsening in systemic sclerosis
Duration:00:11:33
Treating Cytokine Storm Syndrome in COVID-19 patients with glucocorticoids and tocilizumab
Duration:00:23:49
The dose dependent effect of statins on osteoporosis
Duration:00:12:04
A prediction score for individuals at risk to develop rheumatoid arthritis
Duration:00:12:05
Prediction of radiographic progression using synovitis characteristics
Duration:00:10:14
Six-week treatment with low-dose prednisolone in patients with painful hand osteoarthritis
Duration:00:03:08
Highlights from ACR: guselkumab, ixekizumab and secukinumab in SpA
Duration:00:14:55
TULIP 2: Efficacy and Safety of Anifrolumab in Patients
Duration:00:03:51
TULIP 1 - highlights from the ACR meeting
Duration:00:04:50
Capture Hi-C reveals novel drug targets in rheumatic diseases
Duration:00:14:01
EULAR recommendations for the management of systemic lupus erythematosus
Duration:00:10:04
Musculoskeletal diseases on the rise worldwide and affecting developed countries the most
Duration:00:13:17
Three tips to get your manuscript published by ARD
Duration:00:04:39
Early inflammatory arthritis outcomes: what changed in the new millennium?
Duration:00:09:57
Similar performance of Humira and BI695501 biosimilar in active rheumatoid arthritis
Duration:00:15:37